Mineralys Therapeutics sells stock
- 3542 shares sold
- Aggregate market value $78,065.68
- Sold via NASDAQ
David Malcom Rodman, reporting
MLYS
Mineralys Therapeutics, Inc. SEC filings
Every EDGAR filing for Mineralys Therapeutics, Inc. (MLYS), newest first, with AI summaries and stories.
- Ticker
- MLYS
- CIK
- 1933414
- Latest filing
- 5d
Next: earnings expected ~Nov 12 · 10-Q expected ~Nov 12 (deadline Nov 16)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE144Mineralys Therapeutics, Inc.MLYSLIVE ROUTINE4Mineralys Therapeutics, Inc.MLYSLIVE Congleton Jon sold 75,000 MLYS shares
- Sold 75,000 shares on 09/30/2026
- Price range $25.00 to $25.82
- Owned 528,621 shares after sale
Jon Congleton
ROUTINE144Mineralys Therapeutics, Inc.MLYSLIVE Jon Congleton, planned sale of MLYS shares
Jon Congleton, reporting
ROUTINE4Mineralys Therapeutics, Inc.MLYSLIVE Brian Taylor Slingsby, insider filing for MLYS
Brian Taylor Slingsby, reporting
ROUTINE4Mineralys Therapeutics, Inc.MLYSLIVE Eric Warren, insider filing for MLYS
Eric Warren, reporting
ROUTINE144Mineralys Therapeutics, Inc.MLYSLIVE Catalys Pacific Fund, LP, planned sale of MLYS shares
Catalys Pacific Fund, LP, reporting
ROUTINE144Mineralys Therapeutics, Inc.MLYSLIVE Eric Warren, planned sale of MLYS shares
Eric Warren, reporting
ROUTINE4Mineralys Therapeutics, Inc.MLYSLIVE Daphne Karydas, insider filing for MLYS
Daphne Karydas, reporting
ROUTINE144Mineralys Therapeutics, Inc.MLYSLIVE David Malcom Rodman, planned sale of MLYS shares
David Malcom Rodman, reporting
ROUTINE144Mineralys Therapeutics, Inc.MLYSLIVE Daphne Karydas, planned sale of MLYS shares
Daphne Karydas, reporting
ROUTINE144Mineralys Therapeutics, Inc.MLYSLIVE David Malcom Rodman, planned sale of MLYS shares
David Malcom Rodman, reporting
ROUTINE144Mineralys Therapeutics, Inc.MLYSLIVE David Malcom Rodman, planned sale of MLYS shares
David Malcom Rodman, reporting
ROUTINE4Mineralys Therapeutics, Inc.MLYSLIVE Eric Warren, insider filing for MLYS
Eric Warren, reporting
ROUTINE144Mineralys Therapeutics, Inc.MLYSLIVE Eric Warren, planned sale of MLYS shares
Eric Warren, reporting
ROUTINE144Mineralys Therapeutics, Inc.MLYSLIVE David Malcom Rodman, planned sale of MLYS shares
David Malcom Rodman, reporting
ROUTINE144Mineralys Therapeutics, Inc.MLYSLIVE David Malcom Rodman, planned sale of MLYS shares
David Malcom Rodman, reporting
ROUTINE3Mineralys Therapeutics, Inc.MLYSLIVE 3 insider filings
James J. Ferguson III, new insider at MLYS
Show all 3
- 3New insider at MLYS
- 4Insider filing for MLYS
- 4Insider filing for MLYS
James J. Ferguson III, reporting
NOTABLE10-QMineralys Therapeutics, Inc.MLYSLIVE ROUTINE8-KMineralys Therapeutics, Inc.MLYSLIVE ROUTINE144Mineralys Therapeutics, Inc.MLYSLIVE David Malcom Rodman, planned sale of MLYS shares
David Malcom Rodman, reporting
ROUTINESCHEDULE 13G/AMineralys Therapeutics, Inc.MLYSLIVE Ownership stake disclosure by FMR LLC (amended)
FMR LLC, filed by
ROUTINE4Mineralys Therapeutics, Inc.MLYSLIVE Eric Warren, insider filing for MLYS
Eric Warren, reporting
ROUTINE144Mineralys Therapeutics, Inc.MLYSLIVE Eric Warren, planned sale of MLYS shares
Eric Warren, reporting
ROUTINE4Mineralys Therapeutics, Inc.MLYSLIVE David Malcom Rodman, insider filing for MLYS
David Malcom Rodman, reporting
ROUTINE144Mineralys Therapeutics, Inc.MLYSLIVE David Malcom Rodman, planned sale of MLYS shares
David Malcom Rodman, reporting
ROUTINE4Mineralys Therapeutics, Inc.MLYSLIVE 2 insider filings
David Malcom Rodman, insider filing for MLYS
Show all 2
- 4Insider filing for MLYS
- 4Insider filing for MLYS
David Malcom Rodman, reporting
ROUTINE144Mineralys Therapeutics, Inc.MLYSLIVE David Malcom Rodman, planned sale of MLYS shares
David Malcom Rodman, reporting
ROUTINE144/AMineralys Therapeutics, Inc.MLYSLIVE David Malcom Rodman, planned sale of MLYS shares (amended)
David Malcom Rodman, reporting
ROUTINE144Mineralys Therapeutics, Inc.MLYSLIVE 2 Form 144 notices
Jon Congleton, planned sale of MLYS shares
Show all 2
- 144Planned insider sale of MLYS shares
- 144Planned insider sale of MLYS shares
Jon Congleton, reporting
ROUTINE4Mineralys Therapeutics, Inc.MLYSLIVE David Malcom Rodman, insider filing for MLYS
David Malcom Rodman, reporting
ROUTINE144Mineralys Therapeutics, Inc.MLYSLIVE David Malcom Rodman, planned sale of MLYS shares
David Malcom Rodman, reporting
ROUTINE4Mineralys Therapeutics, Inc.MLYSLIVE 2 insider filings
Jon Congleton, insider filing for MLYS
Show all 2
- 4Insider filing for MLYS
- 4Insider filing for MLYS
Jon Congleton, reporting
ROUTINE144Mineralys Therapeutics, Inc.MLYSLIVE Jon Congleton, planned sale of MLYS shares
Jon Congleton, reporting
ROUTINE144Mineralys Therapeutics, Inc.MLYSLIVE Eric Warren, planned sale of MLYS shares
Eric Warren, reporting
ROUTINE4Mineralys Therapeutics, Inc.MLYSLIVE 2 insider filings
David Malcom Rodman, insider filing for MLYS
Show all 2
- 4Insider filing for MLYS
- 4Insider filing for MLYS
David Malcom Rodman, reporting
ROUTINE144Mineralys Therapeutics, Inc.MLYSLIVE 2 Form 144 notices
David Malcom Rodman, planned sale of MLYS shares
Show all 2
- 144Planned insider sale of MLYS shares
- 144Planned insider sale of MLYS shares
David Malcom Rodman, reporting
ROUTINE144Mineralys Therapeutics, Inc.MLYSLIVE David Malcom Rodman, planned sale of MLYS shares
David Malcom Rodman, reporting
ROUTINE4Mineralys Therapeutics, Inc.MLYSLIVE David Malcom Rodman, insider filing for MLYS
David Malcom Rodman, reporting
ROUTINE144Mineralys Therapeutics, Inc.MLYSLIVE David Malcom Rodman, planned sale of MLYS shares
David Malcom Rodman, reporting
ROUTINE144Mineralys Therapeutics, Inc.MLYSLIVE David Malcom Rodman, planned sale of MLYS shares
David Malcom Rodman, reporting
ROUTINE424B5Mineralys Therapeutics, Inc.MLYSLIVE ROUTINE8-KMineralys Therapeutics, Inc.MLYSLIVE ROUTINE8-KMineralys Therapeutics, Inc.MLYSLIVE